CN110613667A - Formula and application of allergy-relieving repairing essence - Google Patents
Formula and application of allergy-relieving repairing essence Download PDFInfo
- Publication number
- CN110613667A CN110613667A CN201911035804.4A CN201911035804A CN110613667A CN 110613667 A CN110613667 A CN 110613667A CN 201911035804 A CN201911035804 A CN 201911035804A CN 110613667 A CN110613667 A CN 110613667A
- Authority
- CN
- China
- Prior art keywords
- extract
- formula
- allergy
- relaxin
- essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Abstract
The invention discloses a formula of a soothing and sensitizing repairing essence and application thereof. A relaxin prost formulation comprising: dendrobium officinale extract, aesculus hippocastanum extract, taxus cuspidata leaf extract, tetrandra root extract, smilax glabra root extract, glycyrrhiza glabra extract and water. Preferably, the composition comprises the following components in percentage by weight: 5% of dendrobium officinale extract, 5% of aesculus hippocastanum extract, 5% of taxus cuspidata leaf extract, 5% of tetrandra root extract, 5% of smilax glabra root extract, 5% of glycyrrhiza glabra extract and the balance of water. An application of a allergy-relieving repair essence formula in essence, cream and facial masks is provided.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a formula of a allergy-relieving restorative essence and application thereof.
Background
The skin often causes symptoms such as whelk, acne, allergic dermatitis, large pores, dark yellow skin and the like due to the influence of human endocrine dyscrasia and other factors and external environment stimulation and the like.
The hormone face is one of drug-induced acne, is also called hormone acne, belongs to one of drug-induced acne, and is a serious skin disease caused by toxic and side effects of hormone due to intermittent or long-term abuse of hormone ointment or cosmetic containing hormone. It is different from common skin sensitivity or allergy, and not only seriously destroys the normal physiological structure and function of the skin, but also influences the whole body health of patients, and brings great trouble to treatment.
The allergic dermatitis is caused by serious water loss of the dermis, reduced water content of keratinocytes, irregular acid-base balance of skin and reduced fat content, and the main clinical manifestations of the allergic dermatitis are as follows: dry skin, itchy skin, abnormal inflammation, red and swollen scar and abnormal precipitation of pigment.
Disclosure of Invention
Based on the above, the invention aims to provide a formula of the allergy-relieving repair essence and application thereof.
The invention relates to a formula of a soothing and sensitizing repairing essence, which comprises the following components: dendrobium officinale extract, aesculus hippocastanum extract, taxus cuspidata leaf extract, tetrandra root extract, smilax glabra root extract, glycyrrhiza glabra extract and water.
In one embodiment, the composition comprises, in weight percent: 5% of dendrobium officinale extract, 5% of aesculus hippocastanum extract, 5% of taxus cuspidata leaf extract, 5% of tetrandra root extract, 5% of smilax glabra root extract, 5% of glycyrrhiza glabra extract and the balance of water.
The allergy-relieving repair essence formula disclosed by the invention takes the combination of extracts of six natural herbs as raw materials, contains active components for improving hormone face and lead-mercury poisoning face, and jointly plays roles in repairing damaged skin, removing speckles and acne marks, effectively treating allergic dermatitis and whitening skin.
The invention further provides an application of the allergy-relieving repairing essence formula in essence, cream and facial masks.
In one embodiment, the allergy-relieving repair essence formula is added into the essence in an amount of 2-5% by mass.
In one embodiment, the amount of the relaxin formulation added to the cream is 0.1-0.5% by weight.
In one embodiment, the amount of the allergy-relieving repair essence in the facial mask is 1-3% by mass.
For a better understanding and practice, the invention is described in detail below with reference to the accompanying drawings.
Drawings
FIG. 1 is a graph showing the effect of the anti-allergic test of the formula of the relaxin according to the present invention.
FIG. 2 is a graph showing the experimental effect of the survival rate of human epidermal cells under ultraviolet irradiation after the use of the formula of the easy-repair agent of the present invention.
FIG. 3 is a graph of the experimental results of high temperature stability of the formula of the relaxin.
FIG. 4 is a graph of the results of an experiment on the light stability of the SMR formulation of the present invention.
FIG. 5 is a graph showing the results of experiments in which the formulations of the relaxin according to the invention promote cell growth.
Detailed Description
The implementations described in the exemplary embodiments below are not intended to represent all implementations consistent with the present disclosure. Rather, they are merely examples of methods consistent with certain aspects of the present disclosure, as detailed in the appended claims.
The terminology used in the present disclosure is for the purpose of describing particular embodiments only and is not intended to be limiting of the disclosure. As used in this disclosure and the appended claims, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It should also be understood that the term "and/or" as used herein refers to and encompasses any and all possible combinations of one or more of the associated listed items.
The invention relates to a formula of a soothing and sensitizing repairing essence, which comprises the following components: dendrobium officinale extract, aesculus hippocastanum extract, taxus cuspidata leaf extract, tetrandra root extract, smilax glabra root extract, glycyrrhiza glabra extract and water.
In one embodiment, the composition comprises, in weight percent: 5% of dendrobium officinale extract, 5% of aesculus hippocastanum extract, 5% of taxus cuspidata leaf extract, 5% of tetrandra root extract, 5% of smilax glabra root extract, 5% of glycyrrhiza glabra extract and the balance of water.
Dendrobium officinale: the dendrobium officinale granules (TPSH) can promote the phagocytic function of macrophages of tumor-bearing animals, enhance the proliferation and differentiation of T lymphocytes and the activity of NK cells, and can obviously improve the serum hemolysin value of the tumor-bearing animals.
Horse chestnut: the extractive solution has strong edema eliminating effect, and can be used for treating varicosis, red swelling and inflammation of skin.
Taxus cuspidata leaves: diminishing inflammation, improving immunity, promoting metabolism, and promoting urination.
And (3) poria cocos extract: is rich in antioxidant, and polyphenol detoxifies oxidant generated in the initial stage of inflammation, especially EGCG of polyphenol has strong allergy-relieving, inflammation-diminishing and calming effects.
Radix stephaniae tetrandrae: has the functions of inducing diuresis to alleviate edema, dispelling wind and relieving pain. It can also be used for treating edema, loempe, dysuresia, rheumatalgia, eczema, skin sore, and hypertension.
And (3) liquorice: it can be used in Chinese medicine and cosmetics; has tranquilizing, anti-irritant, soothing, anti-allergic, and anticancer effects.
The allergy-relieving repair essence formula disclosed by the invention takes the combination of extracts of six natural herbs as raw materials, contains active components for improving hormone face and lead-mercury poisoning face, and jointly plays roles in repairing damaged skin, removing speckles and acne marks, effectively treating allergic dermatitis and whitening skin.
The product of the formula of the allergy-relieving repair essence has the following properties: a light yellow liquid.
Referring to fig. 1, fig. 1 is a graph showing the effect of the anti-allergic experiment of the formula of the sumicidin of the present invention. From the results in fig. 1, it can be seen that the formulations of the present disclosure of the relaxin can reduce mast cell and leukocyte histamine release.
Referring to FIG. 2, FIG. 2 is a graph showing the experimental results of the survival rate of human epidermal cells under UV irradiation after using the formula of the sumicidin of the present invention. As shown in the results of FIG. 2, the UV-B irradiation can improve the cell survival rate of the relaxin.
Referring to fig. 3, fig. 3 is a graph showing the experimental result of high temperature stability of the formula of the sumicidin of the present invention. From the results in FIG. 3, it is clear that the relaxin is very stable even in a high-temperature and high-pressure sterilized state. The color of the treated Shumin is not changed by a 420nm UV/BIS spectrophotometer.
Referring to fig. 4, fig. 4 is a graph showing the experimental results of the light stability of the sumin formulation of the present invention. From the results in FIG. 4, it is clear that the relaxin is very stable even in the greenhouse and under the light conditions. The color of the desensitizing repair substance treated in a greenhouse and by light is not changed by a 420nm UV/BIS spectrophotometer.
Referring to FIG. 5, FIG. 5 is a graph showing the results of experiments on the growth of cells promoted by the formulations of the sumicidin of the present invention. From the results of fig. 5, it is known that the relaxin can effectively promote cell growth.
The experimental results show that the formula of the allergy-relieving repair essence can reduce histamine release of mast cells and leucocytes, improve the survival rate of the cells, and is very stable in a high-temperature and high-pressure sterilization state and under room-temperature illumination, so that the production of the cells is effectively promoted, and therefore, the formula of the allergy-relieving repair essence can be applied to cosmetics.
The application of the allergy-relieving repair essence formula is the application of the allergy-relieving repair essence formula in essence, cream and facial masks.
In one embodiment, the allergy-relieving repair essence formula is added into the essence in an amount of 2-5% by mass.
In one embodiment, the amount of the relaxin formulation added to the cream is 0.1-0.5% by weight.
In one embodiment, the amount of the allergy-relieving repair essence in the facial mask is 1-3% by mass.
The product has the following effects:
1. when the allergy-relieving repair essence formula product is added, the allergy-relieving repair essence formula product has the effects of no redness, no itching and detumescence within 5-10 minutes, has the functions of diminishing inflammation, stopping oxygen and resisting allergy, and does not generate drug resistance after long-term use.
2. Has less irritation to human skin and no allergy.
3. It has effects of softening skin, promoting healing of epidermal scar, and relieving skin feeling.
The allergy-relieving repair essence formula disclosed by the invention is rich in repair essence for improving hormone faces and lead-mercury poisoning faces, and is matched with active components for improving hormone faces and lead-mercury poisoning faces to play a role in repairing skins and enhancing the resistance of skins, so that the skin is repaired and the disease of qi stagnation and blood stasis is improved, liver spots, spleen spots, congestion spots, chloasma, cyasma, sunburn, acne marks and the like caused by qi stagnation and blood stasis are improved, allergic dermatitis is effectively treated, lead-mercury poisoning spots, lead-mercury rebound spots and the like caused by lead-mercury poisoning of skins can be obviously improved, and the skins are recovered to be healthy and transparent.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention.
Claims (6)
1. A relaxin prost formulation, comprising: dendrobium officinale extract, aesculus hippocastanum extract, taxus cuspidata leaf extract, tetrandra root extract, smilax glabra root extract, glycyrrhiza glabra extract and water.
2. The relaxin formulation according to claim 1, comprising, in weight percent: 5% of dendrobium officinale extract, 5% of aesculus hippocastanum extract, 5% of taxus cuspidata leaf extract, 5% of tetrandra root extract, 5% of smilax glabra root extract, 5% of glycyrrhiza glabra extract and the balance of water.
3. Use of a soothing hormone formulation according to claim 1 or 2 in the form of a serum, cream or mask.
4. The application of the allergy-relieving repair essence formula as claimed in claim 3, wherein the addition amount of the allergy-relieving repair essence formula in the essence is 2-5% by mass.
5. The use of the relaxin formulation according to claim 3, wherein the amount of the relaxin formulation added to the cream is 0.1-0.5% by mass.
6. The application of the relaxin and repairin formula according to claim 3, wherein the addition amount of the relaxin and repairin formula in the mask is 1-3% by mass.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911035804.4A CN110613667A (en) | 2019-10-29 | 2019-10-29 | Formula and application of allergy-relieving repairing essence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911035804.4A CN110613667A (en) | 2019-10-29 | 2019-10-29 | Formula and application of allergy-relieving repairing essence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110613667A true CN110613667A (en) | 2019-12-27 |
Family
ID=68926957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911035804.4A Pending CN110613667A (en) | 2019-10-29 | 2019-10-29 | Formula and application of allergy-relieving repairing essence |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110613667A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114983909A (en) * | 2022-07-18 | 2022-09-02 | 维怡美生物科技(广州)有限公司 | Repairing composition, and essence water and essence milk containing same |
| CN115581653A (en) * | 2022-09-30 | 2023-01-10 | 广州市博之越精细化工有限公司 | Allergy-relieving repair agent and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101612292A (en) * | 2009-07-31 | 2009-12-30 | 上海汝莱芾生物科技有限公司 | A kind of application process of natural plants Rhizoma Smilacis Glabrae extract |
| CN103908461A (en) * | 2014-04-10 | 2014-07-09 | 上海紫邦生物医药有限公司 | Application of tetrandrine/dipotassium glycyrrhizinate in preparing anti-allergy drug |
| CN105541857A (en) * | 2016-01-18 | 2016-05-04 | 北京七巧时代科技有限公司 | Tetrandrine extract as well as preparation method and application thereof |
| CN108852998A (en) * | 2018-09-20 | 2018-11-23 | 朱玲 | Improve active component, face mask cream and the preparation method of hormone face, lead mercury poisoning face |
| CN108888525A (en) * | 2018-08-07 | 2018-11-27 | 广州赛隽生物科技有限公司 | A kind of test tube facial mask and preparation method thereof |
-
2019
- 2019-10-29 CN CN201911035804.4A patent/CN110613667A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101612292A (en) * | 2009-07-31 | 2009-12-30 | 上海汝莱芾生物科技有限公司 | A kind of application process of natural plants Rhizoma Smilacis Glabrae extract |
| CN103908461A (en) * | 2014-04-10 | 2014-07-09 | 上海紫邦生物医药有限公司 | Application of tetrandrine/dipotassium glycyrrhizinate in preparing anti-allergy drug |
| CN105541857A (en) * | 2016-01-18 | 2016-05-04 | 北京七巧时代科技有限公司 | Tetrandrine extract as well as preparation method and application thereof |
| CN108888525A (en) * | 2018-08-07 | 2018-11-27 | 广州赛隽生物科技有限公司 | A kind of test tube facial mask and preparation method thereof |
| CN108852998A (en) * | 2018-09-20 | 2018-11-23 | 朱玲 | Improve active component, face mask cream and the preparation method of hormone face, lead mercury poisoning face |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114983909A (en) * | 2022-07-18 | 2022-09-02 | 维怡美生物科技(广州)有限公司 | Repairing composition, and essence water and essence milk containing same |
| CN114983909B (en) * | 2022-07-18 | 2024-01-26 | 维怡美生物科技(广州)有限公司 | Repairing composition and essence lotion and essence emulsion containing same |
| CN115581653A (en) * | 2022-09-30 | 2023-01-10 | 广州市博之越精细化工有限公司 | Allergy-relieving repair agent and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110090191B (en) | After-sun repair composition and cosmetic thereof | |
| Solanki | Treatment of skin diseases through medicinal plants in different regions of the world | |
| KR101908978B1 (en) | A aromatic composition having anti-stress and fatigue relaxing, and a cosmetic composition containing the same | |
| CN110613667A (en) | Formula and application of allergy-relieving repairing essence | |
| KR100564108B1 (en) | Cosmetic composition comprising plant extract having anti-aging effect | |
| CN111110617A (en) | Skin care product prepared from Chinese medicinal extract and its preparation method | |
| CN104027280B (en) | A kind of delay aging drug compositions and the application in cosmetics thereof | |
| CN107519064A (en) | A kind of pure Chinese medicine facial masks for whitening faces and removing spots liquid | |
| CN103550511B (en) | Vegetable composition of a kind of delay skin aging and preparation method thereof | |
| CN106913495A (en) | Profit maintenance skin essence dew and preparation method thereof | |
| CN106619278B (en) | A kind of Chinese traditional medicine composition extract with freckle removing and whitening and application | |
| CN108686009B (en) | Essential oil composition for preventing and/or treating rhinitis, preparation method, application and preparation | |
| CN106890120A (en) | A kind of Chinese medicine Whitening, spot breast and preparation method thereof | |
| CN107184519A (en) | A kind of natural Chinese traditional medicines cosmetics and skincare product and its application method | |
| KR20060093164A (en) | Anti-wrinkle cosmetic composition | |
| CN109010572A (en) | A kind of Chinese medicine composition and its preparation method and application with sun-proof synergy and anti-aging effects | |
| CN110664679B (en) | Traditional Chinese medicine composition with whitening and anti-aging effects and preparation method and application thereof | |
| KR20100010315A (en) | Cosmetic composition inhibiting skin aging and wrinkle formation | |
| CN110772554B (en) | Sodium hyaluronate gel for treating chloasma and preparation method thereof | |
| CN113274319A (en) | After-sun soothing, repairing and brightening skin care composition, preparation method and application | |
| CN108653431B (en) | Pharmaceutical composition for preventing and treating rhinitis, preparation method, application and preparation thereof | |
| CN102885728A (en) | Natural skincare agent material mainly containing Honeysuckle total flavonoids and preparation method of natural healthcare agent material | |
| KR101108710B1 (en) | A cleanser and a manufacturing method therefor | |
| CN110856708A (en) | Facial mask liquid and preparation method thereof | |
| KR102420354B1 (en) | Lotion composition having circulation and vitality and the manufacturing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191227 |
|
| RJ01 | Rejection of invention patent application after publication |